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Abstract 
The generation and ~hara~te~~tion f Swissf3T3 cells which stably over-express protein kinase C (PKC)-a were previously described by us. In 
these cells over-exnression of PKC-a reduced the exnression of enidetmal mowth factor (EGF) receutor molecules i(1990) 3. Biol. Chem. 265, 
1329&13296]. Here we show that the expression of PdGF-a receptks, but not PDGF-/J receptors; was specifically decreased in these cells. Not only 
were the levels of PDGF-a receptor mRNA transcript and protein significantly diminished in the PKC-a. over-producing cells, but their ability to 
respond to short- and long-term growth factor signals was appropriately compromised. This was reflected in a reduced tyrosine autophosphorylation 
signal in response to PDGF-AA, as well as in decreased growth rates of PKC-d over-expressing cells when supplied with external PDGF-AA. A 
similar decrease in PDGF-a receptors was also demonstrated in parental Swissf3T3 cells treated with phorbol esters. Our studies imply that P&X-a 
is involved in a cellular mechanism suppressing the expression of PDGF-a receptors in Swissl3T3 cells. Hence, activation of PKC-a or alterations 
in its cellular levels may affect, in turn, the expression of a specific set of cell surface receptors and their responses to external growth factors. 
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1. Introduction 
The Ca2+ and phospholipid-dependent protein kinase 
C (PKC) is thought to be an important regulator of 
various cellular processes including exocytosis, metabo- 
lism, cell proliferation and gene expression [1,2]. The role 
of PKC in cellular prolife~tion and transfo~ation is 
supported by the fact that phorbol ester tumor promot- 
ers are potent and selective activators of this enzyme [I]. 
In spite of extensive research in the last years, it still 
remains unclear how exactly the signaling pathways, 
which lead to the above events, are activated or sup- 
pressed by PKC. The picture is further complicated by 
the fact that PKC exists as a gene family of classical [3-71 
and PKC-related [8--l l] isoenzymes with vacations in 
properties such as kinetics, substrate specificities, degra- 
dation rates, patterns of translocation, and tissue/cell 
distribution 1121. Moreover, the fact that more than one 
isoform is usually expressed within a particular cell type 
has suggested that these are not mere isoenzymes of 
identical function but rather that they are different en- 
zymes executing distinct cellular functions [ 131. 
In order to examine the role of PKC isoforms in the 
regulation of cellular functions, specific isoforms were 
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stably expressed in cultured cells. Phorbol ester-induced 
morphological changes, enhanced growth in soft agar, 
and tumorogenicity in nude mice resulted from the over- 
production of PKC-/?I and -y isoforms in rat6 and NW 
3T3 cells, respectively [14-161. In contrast to these re- 
ports, over-expression of PKC-cr. in Swissl3T3 [17] was 
not able to confer a transformed phenotype. Similar re- 
sults were reported for the over-expression of PKC-a in 
Balb/c and rat6 cells [ 181. Likewise, the expression of the 
PKC#l isoform in C3H lOT1/2 or rat liver epithelial 
cells was unable to induce changes characteristic of 
transformed cells [19,20]. Moreover, its over-production 
in HT29 colon cancer cells suppressed cellular growth 
events and reduced their tumorogenicity in nude mice 
[21]. The discrepancies een in these different studies may 
be attributed to intrinsic differences between the PKC 
isoenzymes themselves as well as to the specific cell con- 
text into which they were introduced. It appears, how- 
ever, that although PKC by itself may not be sufficient 
to induce complete cell transformation, it can alter spe- 
cific cellular growth characteristics. 
In a previous study, we showed that over-expression 
of PKC-a in Swissl3T3 cells resulted in the reduced ex- 
pression of epidermal growth factor (EGF) receptor 
molecules at the cell surface, correlating with lower levels 
of their mRNA transcripts [17]. In the work described 
herein, we examined the effect of PKC-a on the receptors 
for PDGF. PDGF is a growth factor originally discov- 
ered in serum platelets, which produces a wide range of 
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effects on cells, including motility and growth responses 
[22]. Its action is mainly exerted on cells of mesenchym~ 
origin due to the presence of two receptor subtypes, a 
and /3 [23]. Both homodimers PDGF-AA and -BB, as 
well as the heterodimer, AB, have been isolated from 
normal and transformed cells 124,253. The response of 
different cell types to the three dimeric forms appears to 
be related to the specific receptor subtype expressed on 
the cell’s surface [26-281. The regulation of these recep- 
tors will therefore determine the ability of a cell to re- 
spond physiologically to growth factors in its microenvi- 
ronment. Here we show a specific effect of PKC-a on the 
expression of PDGF-a receptors but not on PDGF-8 
receptors. 
2. Materials and methods 
2.1. Cells and tr~nsfection~ 
All cells were grown in Dulbecco’s modified Eagle’s medium 
(DMEM~ supplemented with 10% heat-inactivate calf serum, 2 mM 
glutamine, and 1% combined antibiotics. The generation of geneticin- 
resistant, PKC-a over-expressing clones was described elsewhere [17]. 
2.2. No&tent blot analysis 
Total cellular RNA was extracted using a modification of the guani- 
dine t~ocyanate method (491. Equal mounts of denatured RNA sam- 
ples were fractionated in 1% agarose gels containing formaldehyde and 
transferred to nitrocellulose filters. Blots were prehybridized for 4 h and 
then hyb~di~d for at least 18 h at 42°C in a solution confining 50% 
formamide, 5 x SSC, 50 mM sodium phosphate, pH 6.5,0.1% bovine 
serum albumin, 0.1% Ficoll-400,0.1% polyvinyl pyrolidine, 0.1% SDS, 
20-25 p&ml denatured &non sperm DNA and 10% dextran sulfate. 
Probes were labeled with [a-“P]dATP by random priming or by nick 
translation and added at lo6 cpm/ml. Filters were subsequently washed 
three times in 3 x SSC, 0.1% SDS at 42*C, and three times in 0.5 x 
SSC. 0.1% SDS at 6S9C. The PDGF-a recentor full-length cDNA was 
recently isolated by Do et al. [50] and the PDGF-p receGor cDNA was 
kindly provided by Y. Yarden ~ei~ann Institute, Israel). 
Cells were grown to subcon~ue~~ in 10 cm plates, incubated for l-2 
h in methionine-free DMEM supplemented with 5% dialyzed FCS and 
then labeled for 2-3 h in the same medium containing 100 PCi per ml 
[3sSJmetbionine (New England Nuclear). After washing twice with PBS, 
the labeled cells were scraped into 1 ml of cold solubilization buffer 
containing 50 mM HEPES, pH 7.5, 150 mM NaCl, 10% glycerol, 1% 
Triton X-100. 2mM EDTA. 1 mM NaF. 1 mM PMSF. 0.4% anrotinin 
(24.4 TIUlmlj, 5 fig/ml leupeptin and ld ,ug/ml soybean trypsin inhibi- 
tor. Cells were solubilized on ice for 20 min with frequent vortexing and 
then ~nt~fug~ at 17,000 x g for 15 min at 4°C. The collected superna- 
tant was subsequently precleared with 1110 of its volume of 50% protein 
A-Sepharose (all protein A-Sepharose beads used were first blocked 
with 10 mg BSAlml) and rotated end-over-end for 45 min at 4°C. The 
solubilized fractions were monitored for total radiolabeled proteins by 
orecinitatinz a small aliquot with 10% TCA. Equivalent amounts of 
iabelkd pro&n were usei in subsequent i~uno~recipitat~ons. In ex- 
oeriments reauirina PDGF stimulation, cells were incubated overnight 
in defined media DCCM (Biological Industries, Beit HaEmek, Israel) 
and Iabeled as above, except that methionine-free DMEM medium 
supplemented with 0.3% dialyzed FCS was used. At the end of the 
labeling period PDGF-AA, at 200 &ml, was added directly to the 
labeling medium. Cells were washed before solubilization with 10 mM 
Tris-HCl, pH 7.4, 140 mM NaCl and 2 mM Na,VO,. 
In several experiments, unlabeled cells were treated at different time 
points with 200 ng/ml TPA in 0.01% dimethyl sulfoxide and 10% calf 
serum, or with the same medium lacking TPA. Cells were washed and 
lysed as above, and equivalent amounts of protein lysates were sub- 
jected to immunopr~ipitation and i~unoblott~ng as described below. 
2.4 immu~~~rec~p~tation experiments 
Anti-phosphotyrosine, anti-PDGF-a receptor (R5) or non-immune 
serum (NS) coupled to protein A-Sepharose, were added to the lysates 
at a ratio of 1: 100 to 150 and rotated end-over-end for 2 h. Ceil lysates 
were subjected to sequential immunoprecipitations: first cleared with 
NS and then reacted with immune-s~cific serum. Both non-i~une 
and immune-specific mmunoprecipitates were washed three times with 
1 ml buffer containing 10 mM Tris, pH 7.5, 140 mM NaCl, 0.1% SDS. 
1% NP-40,lO mM EDTA, 2 mM EGTA, aprotinin, leupeptin, soybean 
trypsin inhibitor and PMSF (in concentrations as above) followed by 
two washes in low-salt buffer containing 10 mM Tris, pH 8.0, 0.1% 
NP-40, 10 mM EDTA, 2 mM EGTA, aprotonjn, leupeptin, ST1 and 
PMSE Sample buffer was added to the washed beads and they were 
boiled for 5 min. The samples were analyzed by gel electrophoresis on 
7.5% SDS-polyac~la~de gels. The fixed and stained gels were treated 
with 2 changes of DMSO and then with 22.5% PPO (25 diphenyl 
oxazole) for 2 h. Dried gels were autoradiographed on Agfa X-ray film 
at -70°C. 
2.5. I~~rnu~ob~ott~g aFla~s~s 
Subconfluent cells in IO-cm dishes were washed with PBS and solubil- 
ized in 0.5 ml of solubilization buffer containing 20 mM HEPES, pH 
7.5, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 1.5 mM MgCl,, 
1 mM EGTA, 10 @ml leupeptin, 1% aprotinin, and 1 mM PMSF. 
Solubilized cells were centrifuged for 10 min at 4°C at 17,000 x g, and 
the protein concentrations of the resulting supematants were deter- 
mined. Equivalent amounts of total lysate protein or washed im- 
munoprecipitates were separated on 7.5% SDS-polyacrylamide gels, 
electrophoretically transferred to nitrocellulose membranes, and re- 
acted with PDGFa (301 or PDGF-/I (a kind gift of C.-H. Heldin) specific 
antibodies. Detection of primary antibodies was performed with 
‘2SI-iabeled protein A, ‘2SI-labeled goat anti-rabbit IgG or with the ECL 
Western blotting detection system (Amersham). 
2.6. Cell grQwf~ assays 
Cultured cetfs were set up in 24-well plates at a density of I x lo4 
cells/well. Initial plating was done in DMEM containing 1% CS. Ap- 
proximately 18 h post-plating the medium was replaced with I ml of 
fresh DMEM containing 1% CS and the appropriate concentration of 
PDGF-AA (a kind gift of Imclone Inc., NY). After a 4 day growth 
period, the cells were quautitated using a modified Crystal violet stain- 
ing procedure 1511. Briefly, cells were first fixed by the addition of 12.5% 
gluteraldehyde directly to the wells. After 30 min, the wells were washed 
3 x with distilled water and 25OylO.l% Crystal violet was added. The 
plates were rocked for 30 mitt, washed three times with distilled water, 
and allowed to air dry. Once dry, 10% acetic acid was added to dissolve 
absorbed dye. After 15 min on a shaker, 100 pl was transferred in 
duplicate from each well to a corresponding well in a 96-well plate. The 
latter plates were read on a micro-ELISA reader, using a test wave- 
length of 570 nm to measure the optical density of dye extracts. 
3. Results and discussion 
3.1. PDGF mxptom in FKC-a over-expressing cells 
The Swiss/3T3-derived cell lines denoted SF1.4 and 
SF3.2 are characterized by stable over-expression of 
PKC-a: with at least 1%fold higher PKC activity and 
40-fold higher immunoreactivity than SC1 control lines 
[17]. In the study presented here we have analyzed the 
receptors for PDGF in these cells since this factor was 
shown to be a potent mitogen for Swissl3T3 cells [29]. 
We first examined the levels of steady-state RNA found 
in these cells coding for both PDGF-ol and -j? type recep- 
tors. RNA isolated from PKC-cx over-expressing (SF 1.4 
and SF3.2) and control (SCl) cells, was probed with 
32P-labeled full-length cDNAs of PDGF-a and PDGF-p 
receptor types. Fig. IA depicts a drastic reduction in 
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Fig. 1. PDGF-a and -/? receptors RNA levels in P&X-u over-expressing 
cells. Total RNA from PKC-IX over~xpressing (SF1.4 and SF3.2) and 
control (SCl) cells were isolated and probed with 32P-labeled full-length 
cDNAs of the PDGF-a (A) and PDGF-JS (B) receptors as described in 
section 2. The amounts of RNA loaded on the gels were similar, as seen 
by the expression of p-actin (A) and ethidum bromide staining of 28 S 
RNA (B) in the a- and p-receptor probed blots. 
PDGF-a receptor transcripts in PKC-a over-expressing 
lines SF1.4 and SF3.2 when compared to control SC1 
cells. Interestingly, this alteration in RNA expression 
was confined to the a-receptor only, since the B-receptor 
probe revealed equivalent amounts of RNA transcripts 
in all the cell lines examined (Fig. 1B). 
In order to confirm that this differential RNA expres- 
sion is also reflected at the protein level, PDGF receptors 
were examined in SFl.4 PKC-ol over-expressing cells, 
which displayed an inte~ediate level of RNA reduction 
when compared to control SC1 cells. Both cell types were 
radiolabeled with ~3sS]methionine and cell lysates were 
immunoprecipitated with a PDGF-a receptor-specific 
~ly~lonal antibody [30]. Fig. 2A shows sign~cant re- 
duction in the incorporation of [35S]methionine into this 
receptor in PKC-a over-expressing cells. Thus, consis- 
tent with the RNA findings, fewer PDGF-a receptor 
polype~tide molecules were synthesized in these cells. 
Furthermore, immunoblot analysis of the same cell ly- 
sates, probed with PDGF-p receptor-specific antibodies, 
confirm also that the latter receptor is expressed at 
simifar levels (Fig. 2B), as was expected from the North- 
ern blot analysis (Fig. 1B). 
Direct activation of PKC by TPA (12~O-tetrade- 
canoylphorbol- 13-acetate) in parental Swissl3T3 cells 
(non-transfected) also caused a specific decrease of 
PDGF-a receptors (Fig. 3). A time-dependent reduction 
in PDGF-a receptors was shown by immunoprecipita- 
tions and Western blot analysis of TPA-treated Swiss/ 
3T3 cells over a 24-h period (Fig. 3). Thus, TPA treat- 
ment of parental Swissl3T3 cells caused a similar effect 
on PDGF-a receptors to that observed by the over- 
expression of PKC-CE in the same cells, suggesting that 
PDGF-a receptor regulation is not merely a result of 
PKC-a over-expression. TPA treatment of Swissl3T3 
cells was previously reported to induce a small but repro- 
- PDGF-P-R 
Fig. 2. ~~u~opr~ipitation and ~~oblotting of PDGF-a and -fl 
receptors in extracts from PKC-a over-expressing cells. (A) Subconflu- 
ent cells were labeled with [35S]methionine  methionine-free DMEM. 
Labeled cells were solubilized, cell lysates normalizd for equal 
amounts of trichloroacetic acid-precipitable radioactivity, and im- 
m~opr~ipitated with anti-PDGF-a receptor antibodies coupled to 
protein A-Sepharose. Irnmunoabsorbed material was fractionated on 
7.5% SDS-polyacrylamide gels and proteins visualized by fluorogra- 
phy. lmmunoprecipitation of PDGF-a receptors from control cells 
(SCl) and from PKCa. expressing cells (SF1.4) is presented. (B) Cell 
extracts prepared from indicated cell lines were subjected to SDS- 
PAGE, followed by immunoblot analysis using anti-PDGF$ receptor 
antibodies as described in section 2. 
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Fig. 3. Effect of TPA treatment on PDGF-a receptors. Parental non- 
infected Swiss/3T3 cells were treated (or not) with TPA (200 nM) over 
a 24 h period. Immunoprecipitations of equivalent amounts of solubil- 
ized protein cell extracts with anti-PDGF-as receptor antibody R5 (301 
were performed as described in section 2. Immunoabsorbed material 
was separated on a 7.5% SDS-polyacrylamide gel, transferred to a 
nitrocellulose membrane, and the blot reacted with the same R5 anti- 
body. Detection of primary antibody was done with the ECL Western 
blotting detection system. 
ducible decrease in [‘251]PDGF binding, apparently me- 
diated by a decrease in the number of available cell sur- 
face PDGF receptors [31]. The relatively small reduction 
in PDGF binding seen in these earlier experiments may 
be explained by the mixture of human platelet-derived 
PDGF isoforms used; a larger specific decrease in 
PDGF-a receptor content, following TPA treatment, 
was most likely masked by the presence of unaffected 
PDGF-8 receptors in these cells which were able to bind 
the BB and AA isoforms of human platelet-extracted 
material [23]. Furthermore, the reduction in PDGF-cx 
receptors obtained in our experiments is most probably 
not due to their internalization and degradation since 
TPA was shown to have no effect on the kinetics of 
internalization and degradation of PDGF receptors in 
Swissl3T3 cells 1311. It is important to note that it was not 
necessary to treat our PKC-ol over-expressing clones 
with phorbol esters in order to induce suppression of 
PDGF-~w: receptor expression. This might be explained 
by the observation that a large proportion of PKC-a 
molecules is already associated with cell membranes in 
these non-stimulated cells [32] and thus, perhaps, par- 
tially activated. 
3.2. Reduced phosphorylation and growth responses to 
PDGF-AA in PKC-a over-expressing cells 
It is well established that PDGF dimers activate the 
intrinsic protein tyrosine kinase activity of its receptors, 
which was found to be essential for the mediation of cell 
growth [23]. We have therefore examined whether the 
specific reduction of PDGF-a receptors in SF1.4 cells 
also affected their response to external growth factor 
stimulation. The a-receptor is the ‘universal’ receptor, 
able to bind all three dimers of PDGF (AA, BB, AB), 
whereas the /I-receptor was shown to bind only PDGF- 
BB and -AB (with less affinity) [33]. Therefore, by stim- 
ulating cells with PDGF-AA, only the a-subtype of 
PDGF receptors is activated. The tyrosine kinase activ- 
ity in response to PDGF-AA was examined in PKC-ct 
over-expressing SF 1.4 cells and SC 1 control cells, using 
anti-phosphotyrosine antibody. As shown in Fig. 4, the 
antibody’s immunoreactivity with the self-phosphoryl- 
ated 185 kDa PDGF-cl receptor in SC1 cells was mark- 
edly higher than in SF1.4 cells. This is most likely due 
to the decreased expression of the receptor protein itself 
in PKC-a over-expressing cells. 
A variety of mutations of the receptors for EGF, insu- 
lin, PDGF and others, resulting in the abolishion of 
tyrosine kinase activity, produced a concomitant loss of 
growth factor-stimulated DNA synthesis [34]. The lower 
PDGF-AA-stimulated receptor tyrosine kinase activity 
in PKC-a over-expressing lines implied decreased bio- 
logical responses to this growth factor in intact cells. To 
SCI SF 1.4 -II 
-+- + PDGF-AA 
Fig. 4. Stimulation of PDGF-a receptor tyrosine kinase by PDGF-AA. 
PKC-a over-expressing (SFl.4) and control (SCl) cells were incubated 
overnight in defined media, labeled with f?S]methionine under low 
serum conditions, and then stimulated for 10 min with 200 nglmi 
PDGF-AA before solubilization. Equivalent amounts of trichlo- 
roacetic acid-precipitable radioactive lysates were immunoprecipitated 
with anti-phosphotyrosine antibodies as described in section 2. Immu- 
noabsorbed material was fractionated on a 7.5% polyacrylamide gef 
and proteins visualized by fluorography. 
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Fig. 5. Effect of PDGF-AA on the growth rates of PKC-a infected cell 
lines. PKC-a over-expressing cells (SF1.4 and SF3.2) and control (SCI) 
cells were grown over a 4 day period in 1% calf serum in the absence 
or presence of increasing (5-50 @ml) amounts of PDGF-AA. Cells 
were quantitated using a Crystal violet staining assay and results are 
expressed as percent activation above the ODS, of cells grown in the 
absence of growth factor. 
test this we examined the growth response of PKC-a 
over-expressing cells, SF1.4 and SF3.2, and control SC1 
cells to increasing amounts of PDGF-AA. As shown in 
Fig. 5, the growth rates of SC1 cells were greatly induced 
with PDGF-AA in a dose-dependent manner. The per- 
cent activation of these cells in media containing 50 ng/ 
ml PDGF-AA reached 120%. However, both cell lines 
over-expressing PKC-a showed a si~ifi~ntly lower re- 
sponse to the externally applied growth factor signal, 
reaching only 44 and 38 percent activation with 50 r&ml 
PDGF-AA in SF1.4 and SF3.2 cells, respectively. 
3.3. Role of PKC-o! in ~e~~fftion f PI3GF receptors 
Swiss/3T3 cells normally express approximately equal 
numbers of a- and /3-PDGF receptor subtypes [33, 351. 
In this report we have shown that increased expression 
or activation of PKC-a in these cells resulted in the re- 
duced receptor content of only PDGF-a receptors, but 
not of PDGF-/I receptors. Our previous studies revealed 
a correlation between the high levels of PKC-a over- 
expressed in Swissl3T3 cells and the reduced expression 
of EGF receptor molecules [17]. FGF receptors were, 
however, unaffected by the over-expression of PKC-a 
(Eldar, H. and Livneh, E., unpublished data). Thus, our 
studies suggest hat PKC-a plays a role in regulating the 
expression of a specific set of cell surface membrane 
receptors. This selective regulation could play a role in 
determining the cells’ sensitivity to external stimuli, of 
particular importance during neoplastic development. 
Indeed, malignancy-dependent changes in the expression 
of PDGF and PDGF receptors were detected in tumors 
of fibrosarcomas or glioblastomas (reviewed in [36]). 
Among other growth factor receptors, only the PDGF 
receptor appears to be capable of mediating ligand- 
induced cell division in normal tissues in the absence of 
other growth factors [29]. However, as noted before, 
signaling by PDGF is complicated by the existence of 
three forms of PDGF ligands (BB, AA, and AB) and 
three types of PDGF receptor dimers (aa, /?/I, and a/3) 
1361. The cellular significance of this complexity is not yet 
clear, but a detailed comparison of the functional activi- 
ties of the a- and /?-receptors revealed similarities as well 
as differences. Whereas both receptors transduce a mito- 
genie response, only the p-receptor mediated chemotaxis 
and actin reorganization in the form of circular mem- 
brane ruffles [37]. Moreover, in cells having both a- and 
B-receptors, activation of the a-receptor inhibited B-re- 
ceptor induced chemotaxis [38,39]. Thus, regulation of 
PDGF-a expression by PKC-a, revealed in our experi- 
ments, may determine at least in part the relative abun- 
dance of PDGF-a and $3 receptors within a particular 
cell and the cellular responsiveness to the different 
isoforms of PDGF. 
Binding of PDGF to its receptors was shown to induce 
association with and phosphorylation of phospholipase 
C-y [40,41], which catalyzes the degradation of 
phosphatidylinositol bisphosphate to diacylglycerol and 
inositol triphosphate. The latter, by releasing Ca2* from 
internal stores acts together with diacylgly~rol to acti- 
vate PKC 121. Since our studies show a role for PKC-a 
in the suppression of PDGF-a receptors expression, 
PDGF binding may actually initiate a negative feedback 
loop, regulating the expression of its a-type receptors 
only. 
A role for PKC was previously proposed in the down- 
regulation of cell surface receptors via a cellular mecha- 
nism that induces their phosphorylation [l]. In fact, 
phospho~lation of EGF receptor in response to PKC 
activation was shown to decrease receptor affinity for its 
ligand [42], reduce its tyrosine kinase activity and the 
mitogenic effects of EGF [43,44]. Treatment of human 
T-lymphocytes with PKC activators also resulted in 
phosphorylation and don-regulation of the T3/T<ell 
antigen receptor complex molecules by increasing their 
internalization rates [45,46]. Thus, phosphorylation of 
certain cell surface receptors by PKC may provide the 
negative signal for their shut-off and their rapid Ioss 
from the cell surface. To our knowledge, no report in the 
literature has described direct phosphorylation of PDGF 
receptors by PKC, and no significant changes in their 
phosphorylation state was observed in cells made PKC 
deficient [35]. On the other hand, our previous 1171 and 
present studies indicate that PKC-a decreases the steady- 
state mRNA and protein levels of EGF and PDGF-a cell 
surface receptors. This could imply the involvement of 
PKC-a in transcriptional or post-transcriptional proc- 
esses modulating either the formation or the stability of 
these mRNAs. Our recent studies suggest potential rele- 
vance of the latter possibility. We have shown that the 
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100 kDa 2-5A synthetase, the enzymatic products of 
which have the capacity to inhibit protein synthesis and 
the stability of specific mRNAs, is up-regulated by PMC- 
d at a post~transcriptional level 1471. In another study, 
Brooks et al. [48] reported that activation of PKC in 
Swiss/3T3 cells by phorbol esters reduced the expression 
of its major phosphorylation substrate, ~80, apparently 
also by a post-transcriptional mechanism affecting the 
stability of its mRNA. It is therefore possible that similar 
molecular m~hanisms might be active in regulating the 
expression of EGF, PDGF-ol and other receptor mole- 
cules. 
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